Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: An autoradiographic study with [3H]citalopram
- 1 June 1993
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 54 (3) , 691-699
- https://doi.org/10.1016/0306-4522(93)90240-g
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindolNeuroscience, 1992
- Cloning and expression of a functional serotonin transporter from rat brainNature, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetineNeuroscience, 1988
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987
- Aminergic systems in Alzheimer's disease and Parkinson's diseaseAnnals of Neurology, 1987
- Peptides and Parkinson's diseaseTrends in Neurosciences, 1985
- High and low affinity [3H]imipramine binding sites in control and Parkinsonian brainsEuropean Journal of Pharmacology, 1985
- An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the ratJournal of Comparative Neurology, 1978
- Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-SyndromKlinische Wochenschrift, 1961